Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-003325
Filing Date
2025-05-09
Accepted
2025-05-09 09:00:18
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR MAR 2025 cardiff_i10q-033125.htm   iXBRL 10-Q 1044223
2 CERTIFICATION cardiff_ex3101.htm EX-31.1 12445
3 CERTIFICATION cardiff_ex3102.htm EX-31.2 12412
4 CERTIFICATION cardiff_ex3201.htm EX-32.1 4480
5 CERTIFICATION cardiff_ex3202.htm EX-32.2 4493
  Complete submission text file 0001683168-25-003325.txt   6197067

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cdif-20250331.xsd EX-101.SCH 54804
7 XBRL CALCULATION FILE cdif-20250331_cal.xml EX-101.CAL 65926
8 XBRL DEFINITION FILE cdif-20250331_def.xml EX-101.DEF 204021
9 XBRL LABEL FILE cdif-20250331_lab.xml EX-101.LAB 355261
10 XBRL PRESENTATION FILE cdif-20250331_pre.xml EX-101.PRE 310893
81 EXTRACTED XBRL INSTANCE DOCUMENT cardiff_i10q-033125_htm.xml XML 920011
Mailing Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169
Business Address 3753 HOWARD HUGHES PARKWAY SUITE 200 LAS VEGAS NV 89169 844-628-2100
Cardiff Lexington Corp (Filer) CIK: 0000811222 (see all company filings)

EIN.: 841044583 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49709 | Film No.: 25928572
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)